Title: Sarah Mcleod: Innovator in Transdermal Formulations
Introduction
Sarah Mcleod is a talented inventor based in Delaware. She has made significant contributions to the field of pharmaceutical formulations, particularly focusing on transdermal delivery systems. Her innovative approach combines traditional analgesics with natural ingredients to enhance therapeutic efficacy.
Latest Patents
Sarah Mcleod holds a patent for a formulation titled "Transdermal Formulation Comprising An Opioid Analgesic And An Aloe Composition." This invention involves a formulation that includes an opioid analgesic from the phenanthrene group or a pharmaceutically acceptable salt thereof as the active ingredient, along with an aloe composition that serves as a transdermal penetration agent. Despite her groundbreaking work, she currently has 0 patents to her name.
Career Highlights
Sarah is associated with Acino AG, a company known for its focus on innovative pharmaceutical solutions. Her work at Acino AG has allowed her to explore new avenues in drug delivery systems, particularly in the realm of pain management.
Collaborations
Sarah collaborates with Peter Altenschoepfer, leveraging their combined expertise to advance their research and development efforts in the pharmaceutical industry.
Conclusion
Sarah Mcleod is an innovative inventor whose work in transdermal formulations showcases her commitment to improving patient care through effective drug delivery systems. Her contributions to the field are noteworthy, and her ongoing research promises to yield further advancements in pharmaceutical technology.